SHL Telemedicine Ltd. (SHLT)
USD 3.02
(-13.69%)
USD 3.02
(-13.69%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 10.43 Million USD | -53.23% |
| 2022 | 22.31 Million USD | -21.34% |
| 2021 | 28.36 Million USD | 167.06% |
| 2020 | 10.62 Million USD | -3.06% |
| 2019 | 10.95 Million USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 1.48 Million USD | -84.45% |
| 2016 | 9.55 Million USD | 1.16% |
| 2015 | 9.44 Million USD | -26.94% |
| 2014 | 12.93 Million USD | -28.97% |
| 2013 | 18.2 Million USD | -8.33% |
| 2012 | 19.86 Million USD | -10.29% |
| 2011 | 22.13 Million USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 7.64 Million USD | -82.78% |
| 2006 | 44.42 Million USD | 36.06% |
| 2005 | 32.64 Million USD | -24.46% |
| 2004 | 43.21 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 9.03 Million USD | 0.0% |
| 2024 Q1 | 9.03 Million USD | -13.67% |
| 2023 Q1 | 20.16 Million USD | -9.61% |
| 2023 Q3 | 15.26 Million USD | 34.84% |
| 2023 Q4 | 10.43 Million USD | -31.64% |
| 2023 FY | 10.43 Million USD | -53.23% |
| 2023 Q2 | 11.31 Million USD | -43.87% |
| 2022 Q1 | 23.49 Million USD | -17.15% |
| 2022 Q3 | 22.31 Million USD | -5.06% |
| 2022 Q4 | 22.31 Million USD | 0.0% |
| 2022 FY | 22.31 Million USD | -21.34% |
| 2022 Q2 | 23.49 Million USD | 0.0% |
| 2021 Q4 | 28.36 Million USD | 0.0% |
| 2021 Q2 | 9.58 Million USD | 0.0% |
| 2021 Q1 | 9.58 Million USD | -9.78% |
| 2021 FY | 28.36 Million USD | 167.06% |
| 2021 Q3 | 28.36 Million USD | 196.02% |
| 2020 Q1 | 10.74 Million USD | -1.93% |
| 2020 Q4 | 10.62 Million USD | 0.0% |
| 2020 Q2 | 10.74 Million USD | 0.0% |
| 2020 FY | 10.62 Million USD | -3.06% |
| 2020 Q3 | 10.62 Million USD | -1.15% |
| 2019 Q3 | 10.95 Million USD | 303.95% |
| 2019 Q1 | 2.71 Million USD | 0.0% |
| 2019 Q2 | 2.71 Million USD | 0.0% |
| 2019 FY | 10.95 Million USD | 0.0% |
| 2019 Q4 | 10.95 Million USD | 0.0% |
| 2018 Q1 | 205 Thousand USD | -86.2% |
| 2018 FY | - USD | -100.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | -100.0% |
| 2018 Q2 | 205 Thousand USD | 0.0% |
| 2017 FY | 1.48 Million USD | -84.45% |
| 2017 Q2 | 8.71 Million USD | 0.0% |
| 2017 Q1 | 8.71 Million USD | -8.86% |
| 2017 Q4 | 1.48 Million USD | 0.0% |
| 2017 Q3 | 1.48 Million USD | -82.94% |
| 2016 Q1 | 14.59 Million USD | 54.48% |
| 2016 FY | 9.55 Million USD | 1.16% |
| 2016 Q4 | 9.55 Million USD | 0.0% |
| 2016 Q3 | 9.55 Million USD | -34.51% |
| 2016 Q2 | 14.59 Million USD | 0.0% |
| 2015 Q2 | 11.53 Million USD | -0.77% |
| 2015 Q1 | 11.62 Million USD | -10.13% |
| 2015 Q4 | 9.44 Million USD | 0.0% |
| 2015 FY | 9.44 Million USD | -26.94% |
| 2015 Q3 | 9.44 Million USD | -18.07% |
| 2014 Q2 | 16.49 Million USD | -3.5% |
| 2014 Q1 | 17.09 Million USD | -6.1% |
| 2014 FY | 12.93 Million USD | -28.97% |
| 2014 Q4 | 12.93 Million USD | -10.94% |
| 2014 Q3 | 14.51 Million USD | -11.98% |
| 2013 Q4 | 18.2 Million USD | -3.01% |
| 2013 FY | 18.2 Million USD | -8.33% |
| 2013 Q1 | 19.5 Million USD | -1.78% |
| 2013 Q2 | 18.96 Million USD | -2.77% |
| 2013 Q3 | 18.77 Million USD | -1.03% |
| 2012 Q2 | 20.36 Million USD | -7.47% |
| 2012 Q4 | 19.86 Million USD | 0.11% |
| 2012 FY | 19.86 Million USD | -10.29% |
| 2012 Q1 | 22 Million USD | -0.6% |
| 2012 Q3 | 19.83 Million USD | -2.57% |
| 2011 Q3 | 23.59 Million USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | 22.13 Million USD | 0.0% |
| 2011 Q4 | 22.13 Million USD | -6.15% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 FY | - USD | -100.0% |
| 2007 FY | 7.64 Million USD | -82.78% |
| 2006 FY | 44.42 Million USD | 36.06% |
| 2005 FY | 32.64 Million USD | -24.46% |
| 2004 FY | 43.21 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 877.57 Million USD | 98.811% |
| GE HealthCare Technologies Inc. | 8.74 Billion USD | 99.881% |
| Sharecare, Inc. | 519 Thousand USD | -1910.416% |
| Progyny, Inc. | 17.24 Million USD | 39.481% |
| Aclarion, Inc. | - USD | -Infinity% |
| CareMax, Inc. | 21.44 Million USD | 51.34% |
| Simulations Plus, Inc. | 531 Thousand USD | -1864.983% |
| CareCloud, Inc. | 10.03 Million USD | -3.956% |
| Forian Inc. | 22.99 Million USD | 54.617% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Minerva Surgical, Inc. | 37.44 Million USD | 72.132% |
| Omnicell, Inc. | 569.66 Million USD | 98.168% |
| Definitive Healthcare Corp. | 242.56 Million USD | 95.698% |
| Zhongchao Inc. | 571.86 Thousand USD | -1724.577% |
| Accolade, Inc. | 208.48 Million USD | 94.995% |
| Streamline Health Solutions, Inc. | 9.06 Million USD | -15.09% |
| Ontrak, Inc. | 1.46 Million USD | -611.252% |
| SOPHiA GENETICS SA | 15.67 Million USD | 33.427% |
| R1 RCM Inc. | 1.64 Billion USD | 99.367% |
| Spok Holdings, Inc. | 6.9 Million USD | -51.174% |
| Privia Health Group, Inc. | 5.24 Million USD | -98.896% |
| EUDA Health Holdings Limited | 75.11 Thousand USD | -13791.522% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 52.68 Million USD | 80.197% |
| TruBridge, Inc. | 198.34 Million USD | 94.739% |
| Nutex Health, Inc. | 26.31 Million USD | 60.349% |
| Renalytix Plc | 4.33 Million USD | -140.916% |
| Sharecare, Inc. | 519 Thousand USD | -1910.416% |
| Health Catalyst, Inc. | 228.03 Million USD | 95.424% |
| 10x Genomics, Inc. | 83.84 Million USD | 87.556% |
| GoodRx Holdings, Inc. | 647.7 Million USD | 98.389% |
| SCWorx Corp. | 90.35 Thousand USD | -11447.34% |
| Schrödinger, Inc. | 111.01 Million USD | 90.601% |
| HealthEquity, Inc. | 874.97 Million USD | 98.807% |
| HealthStream, Inc. | 20.24 Million USD | 48.466% |
| MSP Recovery, Inc. | 678.98 Million USD | 98.463% |
| Augmedix, Inc. | 15.3 Million USD | 31.817% |
| BrightSpring Health Services, Inc. Common Stock | 3.33 Billion USD | 99.687% |
| Ontrak, Inc. | 1.46 Million USD | -611.252% |
| CareCloud, Inc. | 10.03 Million USD | -3.956% |
| Premier, Inc. | 11.17 Million USD | 6.589% |
| Certara, Inc. | 288.21 Million USD | 96.38% |
| GeneDx Holdings Corp. | 52.68 Million USD | 80.197% |
| OneMedNet Corporation | 465.02 Thousand USD | -2143.773% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.33 Billion USD | 99.687% |
| EUDA Health Holdings Limited | 75.11 Thousand USD | -13791.522% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 10.03 Million USD | -3.956% |
| Mangoceuticals, Inc. | 64.96 Thousand USD | -15962.039% |
| CareMax, Inc. | 21.44 Million USD | 51.34% |
| Healthcare Triangle, Inc. | 888 Thousand USD | -1075.007% |
| National Research Corporation | 29.47 Million USD | 64.594% |
| Aclarion, Inc. | - USD | -Infinity% |
| OptimizeRx Corporation | 34.23 Million USD | 69.518% |